» Articles » PMID: 39040675

Addressing Chemically-induced Obesogenic Metabolic Disruption: Selection of Chemicals for Human PPARα, PPARγ Transactivation, and Adipogenesis Test Methods

Overview
Specialty Endocrinology
Date 2024 Jul 23
PMID 39040675
Authors
Affiliations
Soon will be listed here.
Abstract

Whilst western diet and sedentary lifestyles heavily contribute to the global obesity epidemic, it is likely that chemical exposure may also contribute. A substantial body of literature implicates a variety of suspected environmental chemicals in metabolic disruption and obesogenic mechanisms. Chemically induced obesogenic metabolic disruption is not yet considered in regulatory testing paradigms or regulations, but this is an internationally recognised human health regulatory development need. An early step in the development of relevant regulatory test methods is to derive appropriate minimum chemical selection lists for the target endpoint and its key mechanisms, such that the test method can be suitably optimised and validated. Independently collated and reviewed reference and proficiency chemicals relevant for the regulatory chemical universe that they are intended to serve, assist regulatory test method development and validation, particularly in relation to the OECD Test Guidelines Programme. To address obesogenic mechanisms and modes of action for chemical hazard assessment, key initiating mechanisms include molecular-level Peroxisome Proliferator-Activated Receptor (PPAR) α and γ agonism and the tissue/organ-level key event of perturbation of the adipogenesis process that may lead to excess white adipose tissue. Here we present a critical literature review, analysis and evaluation of chemicals suitable for the development, optimisation and validation of human PPARα and PPARγ agonism and human white adipose tissue adipogenesis test methods. The chemical lists have been derived with consideration of essential criteria needed for understanding the strengths and limitations of the test methods. With a weight of evidence approach, this has been combined with practical and applied aspects required for the integration and combination of relevant candidate test methods into test batteries, as part of an Integrated Approach to Testing and Assessment for metabolic disruption. The proposed proficiency and reference chemical list includes a long list of negatives and positives (20 chemicals for PPARα, 21 for PPARγ, and 11 for adipogenesis) from which a (pre-)validation proficiency chemicals list has been derived.

References
1.
Marmugi A, Ducheix S, Lasserre F, Polizzi A, Paris A, Priymenko N . Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology. 2011; 55(2):395-407. DOI: 10.1002/hep.24685. View

2.
Kim J, Kang S, Jung Y, Choi H . Cholecalciferol inhibits lipid accumulation by regulating early adipogenesis in cultured adipocytes and zebrafish. Biochem Biophys Res Commun. 2015; 469(3):646-53. DOI: 10.1016/j.bbrc.2015.12.049. View

3.
Angle B, Do R, Ponzi D, Stahlhut R, Drury B, Nagel S . Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod Toxicol. 2013; 42:256-68. PMC: 3886819. DOI: 10.1016/j.reprotox.2013.07.017. View

4.
Foley B, Doheny D, Black M, Pendse S, Wetmore B, Clewell R . Editor's Highlight: Screening ToxCast Prioritized Chemicals for PPARG Function in a Human Adipose-Derived Stem Cell Model of Adipogenesis. Toxicol Sci. 2016; 155(1):85-100. PMC: 5216650. DOI: 10.1093/toxsci/kfw186. View

5.
Al Sharif M, Tsakovska I, Alov P, Vitcheva V, Diukendjieva A, Pajeva I . Molecular Modeling Approach to Study the PPARγ-Ligand Interactions. Methods Mol Biol. 2019; 1966:261-289. DOI: 10.1007/978-1-4939-9195-2_22. View